Fierce Pharma
DECEMBER 12, 2023
Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.
World of DTC Marketing
JUNE 22, 2022
The new initiative, Care Studio, aims at doctors rather than patients. Then there is the cost of generic drugs. A recent study in the Annals of Internal Medicine took a look at almost 90 generic drugs that the Medicare Part D program pays for, finding that Medicare could’ve saved $3.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 4, 2021
is a topical prescription medicine used to treat acne vulgaris. The launch of our first-to-market authorized generic version of Epiduo® Forte Gel in the U.S. provides patients with another important treatment option,” said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA.
The Pharma Data
MARCH 9, 2021
“This first-to-market generic version of AZOPT ® (brinzolamide ophthalmic suspension) 1% in the U.S. provides patients with another important treatment option,” said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA. What should I tell my doctor before taking brinzolamide ophthalmic suspension 1%?
The Pharma Data
MARCH 7, 2022
(NYSE and TASE: TEVA), announced today the launch of a first generic version of Revlimid® 1 (lenalidomide capsules), in 5mg, 10mg, 15mg, and 25mg strengths, in the United States. Please see the below “What are lenalidomide capsules?” “The launch of our first generic version of Revlimid® in the U.S. Revlimid® had annual sales of $2.3
World of DTC Marketing
AUGUST 7, 2022
First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. Patients and doctors are tired, and insurance companies are raising rates after two years of making a surplus because nobody went to the doctor during the pandemic. The result:?
FDA Law Blog
AUGUST 21, 2023
Brand drugs, generic drugs, and medical devices alike have all been the target of state failure-to-warn litigation; in a recent case, OTC acetaminophen is the target. Health care professionals should continue to follow the recommendations in the drug labels when prescribing pain medicines to pregnant patients.
Expert insights. Personalized for you.
142 
Let's personalize your content